{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:45:57Z","timestamp":1773362757900,"version":"3.50.1"},"reference-count":115,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:p>The incidence of retinopathy of prematurity (ROP) is showing an increasing trend in the United States. This may be because of increasing survival rates among extremely preterm infants (&amp;lt;25 weeks\u2019 gestation) and targeting higher oxygen saturation. Five randomized clinical trials of low versus high oxygen saturation target ranges found increased mortality in the low oxygen saturation target group and an increased incidence of ROP in the high oxygen saturation target group. The American Academy of Pediatrics recommends using an oxygen saturation target range of 90% to 95% in extremely low-birthweight infants. The change of practice to target this higher oxygen saturation range, from admission until discharge, may be contributing to the increasing incidence of ROP in extremely preterm infants. To decrease the incidence of ROP without increasing mortality, 2 new cohort trials suggest gradually increasing oxygen saturation targets as preterm infants mature. There is evidence that human milk, vitamin A, and omega-3 fatty acids can help, in addition to continuous oxygen saturation monitoring, to decrease the risk of ROP. We review this literature and provide a meta-analysis to evaluate the evidence.<\/jats:p>","DOI":"10.1542\/neo.21-4-e249","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T13:24:37Z","timestamp":1585747477000},"page":"e249-e263","source":"Crossref","is-referenced-by-count":55,"title":["Strategies to Prevent Severe Retinopathy of Prematurity: A 2020 Update and Meta-analysis"],"prefix":"10.1542","volume":"21","author":[{"given":"Talkad S.","family":"Raghuveer","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zackula","sequence":"additional","affiliation":[{"name":"Research, University of Kansas School of Medicine at Wichita, Wichita, KS"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"2021121001315486500_B1","first-page":"S80","article-title":"Can we stop the current epidemic of blindness from retinopathy of prematurity?","volume":"53","author":"Dutta","year":"2016","journal-title":"Indian Pediatr"},{"issue":"6","key":"2021121001315486500_B2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaapos.2012.09.004","article-title":"An update on progress and the changing epidemiology of causes of childhood blindness worldwide","volume":"16","author":"Kong","year":"2012","journal-title":"J AAPOS"},{"issue":"10","key":"2021121001315486500_B3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012","volume":"314","author":"Stoll","year":"2015","journal-title":"JAMA"},{"issue":"7","key":"2021121001315486500_B4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3928\/23258160-20170630-06","article-title":"The epidemiology of retinopathy of prematurity in the United States","volume":"48","author":"Ludwig","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"2","key":"2021121001315486500_B5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcjo.2018.05.005","article-title":"Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre","volume":"54","author":"Isaza","year":"2019","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"2021121001315486500_B6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3928\/01913913-20190205-01","article-title":"Temporal profile of retinopathy of prematurity in extremely premature compared to premature infants","volume":"56","author":"Venincasa","year":"2019","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"2021121001315486500_B7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1542\/peds.106.5.998","article-title":"Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years","volume":"106","author":"Msall","year":"2000","journal-title":"Pediatrics"},{"issue":"6","key":"2021121001315486500_B8","doi-asserted-by":"crossref","first-page":"F532","DOI":"10.1136\/archdischild-2016-312533","article-title":"Severe retinopathy of prematurity predicts delayed white matter maturation and poorer neurodevelopment","volume":"102","author":"Glass","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"2021121001315486500_B9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/jnp.12069","article-title":"The long-term outcome of extremely preterm (&lt;28 weeks\u2019 gestational age) infants with and without severe retinopathy of prematurity","volume":"10","author":"Molloy","year":"2016","journal-title":"J Neuropsychol"},{"issue":"4","key":"2021121001315486500_B10","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"2021121001315486500_B11","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2018-3537","article-title":"Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment","volume":"144","author":"Natarajan","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"2021121001315486500_B12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaapos.2017.10.006","article-title":"Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity","volume":"22","author":"Kennedy","year":"2018","journal-title":"J AAPOS"},{"issue":"2","key":"2021121001315486500_B13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clp.2013.02.008","article-title":"Outcome of retinopathy of prematurity","volume":"40","author":"Holmstr\u00f6m","year":"2013","journal-title":"Clin Perinatol"},{"issue":"2","key":"2021121001315486500_B14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaapos.2012.10.025","article-title":"Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age","volume":"17","author":"Quinn","year":"2013","journal-title":"J AAPOS"},{"issue":"11","key":"2021121001315486500_B15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","article-title":"Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial","volume":"132","author":"Geloneck","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2021121001315486500_B16","first-page":"135","article-title":"Review of effects of anti-VEGF treatment on refractive error","volume":"8","author":"Mintz-Hittner","year":"2016","journal-title":"Eye Brain"},{"issue":"4","key":"2021121001315486500_B17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/IAE.0000000000000380","article-title":"Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between ranibizumab and bevacizumab","volume":"35","author":"Chen","year":"2015","journal-title":"Retina"},{"issue":"6","key":"2021121001315486500_B18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaapos.2011.07.017","article-title":"Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial","volume":"15","author":"VanderVeen","year":"2011","journal-title":"J AAPOS"},{"issue":"5","key":"2021121001315486500_B19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9394(99)00475-4","article-title":"Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity","volume":"129","author":"Lambert","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2021121001315486500_B20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1120672118770557","article-title":"Systematic review and meta-analysis of the negative outcomes of retinopathy of prematurity treated with laser photocoagulation","volume":"29","author":"Liang","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"2021121001315486500_B21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.clp.2014.08.011","article-title":"Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity","volume":"41","author":"Hartnett","year":"2014","journal-title":"Clin Perinatol"},{"issue":"2","key":"2021121001315486500_B22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2021121001315486500_B23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00417-015-2996-0","article-title":"Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab","volume":"254","author":"Zhou","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"2021121001315486500_B24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","article-title":"Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"2021121001315486500_B25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-Vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"2021121001315486500_B26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/08820530902800314","article-title":"Retinopathy of prematurity: current concepts in molecular pathogenesis","volume":"24","author":"Heidary","year":"2009","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"2021121001315486500_B27","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division. Evidence that \u2018physiological hypoxia\u2019 is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7 pt 1","key":"2021121001315486500_B28","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"issue":"7","key":"2021121001315486500_B29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"issue":"26","key":"2021121001315486500_B30","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med"},{"key":"2021121001315486500_B31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4939-3628-1_22","article-title":"Models of oxygen induced retinopathy in rodents","volume":"1430","author":"Gammons","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"10","key":"2021121001315486500_B32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2021121001315486500_B33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/mvre.2002.2426","article-title":"Erythropoietin and VEGF exhibit equal angiogenic potential","volume":"64","author":"Jaquet","year":"2002","journal-title":"Microvasc Res"},{"issue":"2","key":"2021121001315486500_B34","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"issue":"10","key":"2021121001315486500_B35","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2021121001315486500_B36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-3782(86)90096-4","article-title":"Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally","volume":"13","author":"Lineham","year":"1986","journal-title":"Early Hum Dev"},{"issue":"7","key":"2021121001315486500_B37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat Med"},{"issue":"5","key":"2021121001315486500_B38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jpeds.2011.04.039","article-title":"Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities","volume":"159","author":"Martin","year":"2011","journal-title":"J Pediatr"},{"issue":"11","key":"2021121001315486500_B39","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"issue":"2","key":"2021121001315486500_B40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archophthalmol.2010.346","article-title":"Screening for retinopathy of prematurity in infants born before 27 weeks\u2019 gestation in Sweden","volume":"129","author":"Austeng","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2021121001315486500_B41","first-page":"576","article-title":"Variable oxygen exposure causes preretinal neovascularization in the newborn rat","volume":"34","author":"Penn","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2021121001315486500_B42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"2021121001315486500_B43","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2021121001315486500_B44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10456-018-9618-5","article-title":"Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy","volume":"21","author":"Simmons","year":"2018","journal-title":"Angiogenesis"},{"issue":"9","key":"2021121001315486500_B45","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","article-title":"Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"2021121001315486500_B46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCRESAHA.110.221317","article-title":"Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy","volume":"107","author":"Stahl","year":"2010","journal-title":"Circ Res"},{"issue":"2","key":"2021121001315486500_B47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000322848","article-title":"A paradigm shift in the prevention of retinopathy of prematurity","volume":"100","author":"Raghuveer","year":"2011","journal-title":"Neonatology"},{"issue":"2","key":"2021121001315486500_B48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5694\/j.1326-5377.1951.tb109040.x","article-title":"Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach","volume":"2","author":"Campbell","year":"1951","journal-title":"Med J Aust"},{"issue":"4","key":"2021121001315486500_B49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archopht.1956.00930040489001","article-title":"Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen","volume":"56","author":"Kinsey","year":"1956","journal-title":"AMA Arch Opthalmol"},{"key":"2021121001315486500_B50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3476(60)80083-2","article-title":"Recent increase in mortality from hyaline membrane disease","volume":"57","author":"Avery","year":"1960","journal-title":"J Pediatr"},{"issue":"16","key":"2021121001315486500_B51","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM199204163261603","article-title":"A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity","volume":"326","author":"Flynn","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"2021121001315486500_B52","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","article-title":"Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes","volume":"105","year":"2000","journal-title":"Pediatrics"},{"issue":"21","key":"2021121001315486500_B53","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa0911781","article-title":"Target ranges of oxygen saturation in extremely preterm infants","volume":"362","author":"Carlo","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121001315486500_B54","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1136\/adc.2007.135285","article-title":"Arterial oxygen tension (Pao2) values in infants &lt;29 weeks of gestation at currently targeted saturations","volume":"94","author":"Quine","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2021121001315486500_B55","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1056\/NEJMoa1302298","article-title":"Oxygen saturation and outcomes in preterm infants","volume":"368","author":"The BOOST II United Kingdom, Australia, and New Zealand Collaborative Groups.","year":"2013","journal-title":"N Engl J Med"},{"issue":"20","key":"2021121001315486500_B56","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2013.5555","article-title":"Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial","volume":"309","author":"Schmidt","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"2021121001315486500_B57","first-page":"CD011190","article-title":"Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants","volume":"4","author":"Askie","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021121001315486500_B58","doi-asserted-by":"crossref","first-page":"e20161576","DOI":"10.1542\/peds.2016-1576","article-title":"Oxygen targeting in extremely low birth weight infants","volume":"138","author":"Cummings","year":"2016","journal-title":"Pediatrics"},{"key":"2021121001315486500_B59","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpeds.2015.10.005","article-title":"Higher rates of retinopathy of prematurity after increasing oxygen saturation targets for very preterm infants: experience in a single center","volume":"168","author":"Manley","year":"2016","journal-title":"J Pediatr"},{"issue":"4","key":"2021121001315486500_B60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaophthalmol.2018.7021","article-title":"Comparison of biphasic vs static oxygen saturation targets among infants with retinopathy of prematurity","volume":"137","author":"Shukla","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"2021121001315486500_B61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/pr.2016.98","article-title":"Graded oxygen saturation targets and retinopathy of prematurity in extremely preterm infants","volume":"80","author":"Cayabyab","year":"2016","journal-title":"Pediatr Res"},{"issue":"2","key":"2021121001315486500_B62","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1167\/iovs.16-20822","article-title":"Use of a supplemental oxygen protocol to suppress progression of retinopathy of prematurity","volume":"58","author":"Colaizy","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2021121001315486500_B63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.jp.7211040","article-title":"Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants","volume":"24","author":"York","year":"2004","journal-title":"J Perinatol"},{"issue":"5","key":"2021121001315486500_B64","doi-asserted-by":"crossref","first-page":"F395","DOI":"10.1136\/archdischild-2016-312172","article-title":"The effect of implementing an automated oxygen control on oxygen saturation in preterm infants","volume":"102","author":"Van Zanten","year":"2017","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"2021121001315486500_B65","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/jp.2016.131","article-title":"Early hyperoxia burden detected by cerebral near-infrared spectroscopy is superior to pulse oximetry for prediction of severe retinopathy of prematurity","volume":"36","author":"Vesoulis","year":"2016","journal-title":"J Perinatol"},{"issue":"6","key":"2021121001315486500_B66","doi-asserted-by":"crossref","first-page":"E1307","DOI":"10.3390\/nu11061307","article-title":"A review of bioactive factors in human breastmilk: a focus on prematurity","volume":"11","author":"Gila-Diaz","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"2021121001315486500_B67","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.jp.7210548","article-title":"Association of human milk feedings with a reduction in retinopathy of prematurity among very low birthweight infants","volume":"21","author":"Hylander","year":"2001","journal-title":"J Perinatol"},{"issue":"1","key":"2021121001315486500_B68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archpedi.157.1.66","article-title":"The effect of maternal milk on neonatal morbidity of very low-birth-weight infants","volume":"157","author":"Furman","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2021121001315486500_B69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2006-1465","article-title":"Human milk intake and retinopathy of prematurity in extremely low birth weight infants","volume":"120","author":"Heller","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"2021121001315486500_B70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.earlhumdev.2010.05.015","article-title":"The influence of early postnatal nutrition on retinopathy of prematurity in extremely low birth weight infants","volume":"86","author":"Porcelli","year":"2010","journal-title":"Early Hum Dev"},{"issue":"2","key":"2021121001315486500_B71","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0031-1295652","article-title":"Human milk versus formula feeding among preterm infants: short-term outcomes","volume":"29","author":"Maayan-Metzger","year":"2012","journal-title":"Am J Perinatol"},{"key":"2021121001315486500_B72","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S0378-3782(13)70019-7","article-title":"Human milk feeding prevents retinopathy of prematurity (ROP) in preterm VLBW neonates","volume":"89","author":"Manzoni","year":"2013","journal-title":"Early Hum Dev"},{"issue":"7","key":"2021121001315486500_B73","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/jp.2013.2","article-title":"Impact of early human milk on sepsis and health-care costs in very low birth weight infants","volume":"33","author":"Patel","year":"2013","journal-title":"J Perinatol"},{"key":"2021121001315486500_B74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpeds.2015.10.080","article-title":"Does breastmilk influence the development of bronchopulmonary dysplasia?","volume":"169","author":"Spiegler","year":"2016","journal-title":"J Pediatr"},{"issue":"6","key":"2021121001315486500_B75","doi-asserted-by":"crossref","first-page":"e1576","DOI":"10.1542\/peds.2015-2372","article-title":"Human milk feeding as a protective factor for retinopathy of prematurity: a meta-analysis","volume":"136","author":"Zhou","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"2021121001315486500_B76","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/jp.2016.98","article-title":"Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update","volume":"36","author":"Bharwani","year":"2016","journal-title":"J Perinatol"},{"issue":"4","key":"2021121001315486500_B77","doi-asserted-by":"crossref","first-page":"e20153387","DOI":"10.1542\/peds.2015-3387","article-title":"Interventions to prevent retinopathy of prematurity: a meta-analysis","volume":"137","author":"Fang","year":"2016","journal-title":"Pediatrics"},{"issue":"22","key":"2021121001315486500_B78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15585\/mmwr.mm6822a1","article-title":"Receipt of breast milk by gestational age - United States, 2017","volume":"68","author":"Chiang","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2021121001315486500_B79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1542\/peds.2004-1974","article-title":"Randomized trial of donor human milk versus preterm formula as substitutes for mothers\u2019 own milk in the feeding of extremely premature infants","volume":"116","author":"Schanler","year":"2005","journal-title":"Pediatrics"},{"issue":"3","key":"2021121001315486500_B80","first-page":"19","article-title":"Donor human milk versus mother\u2019s own milk in preterm VLBWIs: a case control study","volume":"26","author":"Giuliani","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"issue":"4","key":"2021121001315486500_B81","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000320159","article-title":"Postnatal docosahexaenoic acid deficiency is an inevitable consequence of current recommendations and practice in preterm infants","volume":"98","author":"Lapillonne","year":"2010","journal-title":"Neonatology"},{"issue":"2","key":"2021121001315486500_B82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.2010-2427","article-title":"Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants","volume":"127","author":"Pawlik","year":"2011","journal-title":"Pediatrics"},{"issue":"6","key":"2021121001315486500_B83","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0148607113499373","article-title":"Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study","volume":"38","author":"Pawlik","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2021121001315486500_B84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clnesp.2017.04.004","article-title":"Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial","volume":"20","author":"Najm","year":"2017","journal-title":"Clin Nutr ESPEN"},{"issue":"3","key":"2021121001315486500_B85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamaophthalmol.2017.6658","article-title":"Association of retinopathy of prematurity with low levels of arachidonic acid: a secondary analysis of a randomized clinical trial","volume":"136","author":"L\u00f6fqvist","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"17","key":"2021121001315486500_B86","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2174\/1381612824666180601094849","article-title":"The efficacy of omega-3 supplement on prevention of retinopathy of prematurity in premature infants: a randomized double-blinded controlled trial","volume":"24","author":"Khalesi","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"7","key":"2021121001315486500_B87","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jpen.1497","article-title":"Enteral docosahexaenoic acid and retinopathy of prematurity: a randomized clinical trial","volume":"43","author":"Bernabe-Garc\u00eda","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"1","key":"2021121001315486500_B88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.earlhumdev.2013.11.002","article-title":"The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial","volume":"90","author":"Beken","year":"2014","journal-title":"Early Hum Dev"},{"issue":"7","key":"2021121001315486500_B89","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-0036-1597131","article-title":"Parenteral fish-oil lipid emulsions in the prevention of severe retinopathy of prematurity: a systematic review and meta-analysis","volume":"34","author":"Vayalthrikkovil","year":"2017","journal-title":"Am J Perinatol"},{"issue":"3","key":"2021121001315486500_B90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MPG.0000000000002375","article-title":"A randomized trial of maternal docahexaenoic acid supplementation to reduce inflammation in extremely preterm infants","volume":"69","author":"Valentine","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021121001315486500_B91","article-title":"Early vitamin a supplementation improves the outcome of retinopathy of prematurity in extremely preterm infants [published online ahead of print April 5]","author":"Sun","year":"2019","journal-title":"Retina"},{"issue":"2","key":"2021121001315486500_B92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3476(87)80086-0","article-title":"Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia","volume":"111","author":"Shenai","year":"1987","journal-title":"J Pediatr"},{"issue":"2","key":"2021121001315486500_B93","doi-asserted-by":"crossref","first-page":"F103","DOI":"10.1136\/adc.2004.057547","article-title":"Vitamin A and preterm infants: what we know, what we don\u2019t know, and what we need to know","volume":"90","author":"Mactier","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"8","key":"2021121001315486500_B94","first-page":"CD000501","article-title":"Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants","volume":"8","author":"Darlow","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2021121001315486500_B95","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1067\/mpd.2003.214","article-title":"A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants","volume":"142","author":"Ambalavanan","year":"2003","journal-title":"J Pediatr"},{"issue":"6","key":"2021121001315486500_B96","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jpeds.2011.12.013","article-title":"Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity","volume":"160","author":"Mactier","year":"2012","journal-title":"J Pediatr"},{"issue":"3","key":"2021121001315486500_B97","doi-asserted-by":"crossref","first-page":"267","DOI":"10.33549\/physiolres.930754","article-title":"Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity","volume":"55","author":"Ozkan","year":"2006","journal-title":"Physiol Res"},{"issue":"6","key":"2021121001315486500_B98","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0891-5849(96)00479-0","article-title":"Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity","volume":"22","author":"Penn","year":"1997","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2021121001315486500_B99","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1542\/peds.79.1.61","article-title":"Oral vitamin E supplementation for the prevention of anemia in premature infants: a controlled trial","volume":"79","author":"Zipursky","year":"1987","journal-title":"Pediatrics"},{"issue":"5","key":"2021121001315486500_B100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0022-3476(89)80149-0","article-title":"Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial","volume":"114","author":"Johnson","year":"1989","journal-title":"J Pediatr"},{"issue":"12","key":"2021121001315486500_B101","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0161-6420(84)34106-9","article-title":"Suppression of severe retinopathy of prematurity with vitamin E supplementation: ultrastructural mechanism of clinical efficacy","volume":"91","author":"Hittner","year":"1984","journal-title":"Ophthalmology"},{"issue":"23","key":"2021121001315486500_B102","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM198112033052301","article-title":"Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants","volume":"305","author":"Hittner","year":"1981","journal-title":"N Engl J Med"},{"issue":"8281","key":"2021121001315486500_B103","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(82)92276-0","article-title":"Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia: a controlled trial","volume":"1","author":"Finer","year":"1982","journal-title":"Lancet"},{"key":"2021121001315486500_B104","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1749-6632.1982.tb31283.x","article-title":"Effect of vitamin E on the development of oxygen-induced lung injury in neonates","volume":"393","author":"Ehrenkranz","year":"1982","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"2021121001315486500_B105","first-page":"CD003665","article-title":"Vitamin E supplementation for prevention of morbidity and mortality in preterm infants","author":"Brion","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2021121001315486500_B106","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-3476(97)70031-3","article-title":"Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials","volume":"131","author":"Raju","year":"1997","journal-title":"J Pediatr"},{"key":"2021121001315486500_B107","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpeds.2017.12.062","article-title":"Effect of maternal smoking on plasma and urinary measures of vitamin E isoforms in the first month of after extreme preterm birth","volume":"197","author":"Stone","year":"2018","journal-title":"J Pediatr"},{"issue":"11","key":"2021121001315486500_B108","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/nu8110681","article-title":"A comparison of nutritional antioxidant content in breast milk, donor milk and infant formulas","volume":"8","author":"Hanson","year":"2016","journal-title":"Nutrients"},{"key":"2021121001315486500_B109","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpeds.2018.10.033","article-title":"rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial","volume":"206","author":"Ley","year":"2019","journal-title":"J Pediatr"},{"issue":"16","key":"2021121001315486500_B110","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1001\/jama.2018.14996","article-title":"Effects of myo-inositol on type 1 retinopathy of prematurity among preterm infants &lt;28 weeks\u2019 gestational age: a randomized clinical trial","volume":"320","author":"Phelps","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"2021121001315486500_B111","article-title":"Dark-Rearing (DR) precludes the initiating event in OIR and eliminates the pathology seen in the second phase of disease: rationale for novel non-invasive treatment for ROP","volume":"157","author":"Chan-Ling","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"2021121001315486500_B112","first-page":"1922","article-title":"Intraretinal oxygen consumption in the rat in vivo","volume":"43","author":"Cringle","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2021121001315486500_B113","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41372-018-0177-9","article-title":"Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors","volume":"38","author":"Gaynon","year":"2018","journal-title":"J Perinatol"},{"issue":"11","key":"2021121001315486500_B114","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1111\/trf.13785","article-title":"Adverse effects of red blood cell transfusions in neonates: a systematic review and meta-analysis","volume":"56","author":"Keir","year":"2016","journal-title":"Transfusion"},{"key":"2021121001315486500_B115","first-page":"CD011893","article-title":"Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants","volume":"3","author":"Kaempfen","year":"2018","journal-title":"Cochrane Database Syst Rev"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/4\/e249\/822848\/neoreviews_042019rev00055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/4\/e249\/822848\/neoreviews_042019rev00055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T06:14:44Z","timestamp":1666246484000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/21\/4\/e249\/88504\/Strategies-to-Prevent-Severe-Retinopathy-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":115,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.21-4-e249","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}